Source: Eur Respir J 2009; 34: 740
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Kumamoto M., Nishiwaki T., Matsuo N., Kimura H., Matsushima K.. Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury. Eur Respir J 2009; 34: 740

Member's Comments

No comment yet.

Related content which might interest you: HGF expressing stem cells in the human fibrotic lung originate from the bone marrow Source: Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both? Year: 2011 The contribution of bone marrow derived progenitor cells to lung remodelling Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling Year: 2008 Bone marrow derived mesenchymal stem cells accelerate alveolar epithelial repair in vitro Source: Annual Congress 2007 - Cell-based tissue modulation: the good and the ugly? Year: 2007 Impaired migration of bone marrow mesenchymal stem cells in COPD Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Electroporation of Hepatocyte growth factor to the lung induces migration of bone marrow mesenchymal stem cells and reduces lung fibrosis Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 The impact of bone marrow stem cells therapy in pulmonary and extrapulmonary acute lung injury Source: Annual Congress 2008 - Pathophysiology of acute lung injury Year: 2008 Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Expression of the biological axis VEGF-CXCL12/CXCR4 in bone marrow mesenchymal stem cells (BM MSCs) in patients with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008 Successful transplantation of rat mesenchymal stem cells, for the therapy of bleomycin induced lung injury Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis Year: 2010 Phenotypical and molecular characteristics of bone marrow mesenchymal stem cells in rheumatoid lung Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 HGF expressing stem cells in usual interstitial pneumonia originate from the bone marrow and are antifibrotic Source: Research Seminar 2014 - The many faces of stem cells in respiratory diseases Year: 2014 A study on markers of pulmonary endothelial cells in acute lung injury induced by bone marrow extract injection inrabbits Source: Eur Respir J 2004; 24: Suppl. 48, 720s Year: 2004 Mechanical programming of mesenchymal stromal cells to treat lung fibrosis Source: ERS Lung Science Conference 2018 Year: 2018 Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Bone marrow-derived mononuclear cell therapy reduces lung and distal organ damage in severe sepsis Source: Annual Congress 2010 - Acute lung injury and ventilator-induced lung injury Year: 2010 Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells Source: Eur Respir J 2012; 39: 446-457 Year: 2012